0

Skin Cancer Treatment Market Expected to Reach $14.5 Billion by 2031—Allied Market Research

 
2022
Skin Cancer Treatment Market

Report Code : A17526

quote Rise in the prevalence of melanoma and non-melanoma skin cancer, increase in the number of product launch for skin cancer treatment and rise in awareness among people regarding skin cancer. Moreover, technological advancement in healthcare sector expected to offer profitable opportunities for growth of the market during the forecast period. quote

Onkar Sumant - Manager
Life Sciences at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, “Skin Cancer Treatment Market," The skin cancer treatment market size was valued at $7.2 billion in 2021, and is estimated to reach $14.5 billion by 2031, growing at a CAGR of 7.3% from 2022 to 2031.

Skin cancer is the most prevalent type of cancer across the globe. Melanoma or non-melanoma skin cancer (NMSC) are the two main categories of skin cancer. Due to inadequate diagnostic standards and underreporting, it is challenging to pinpoint the exact incidences of skin cancer. Head and neck are common areas where skin malignancies are found, which can cause serious morbidity during diagnosis and treatment. Medicated treatment options include chemotherapy, immunotherapy, and targeted therapy. Sunscreen use is essential for proper sun safety. The primary etiological component in the emergence of cutaneous cancers is ultraviolet (UV) sun radiation. Majority of NMSC and melanoma cases can be attributed to UV exposure.

Increase in prevalence of skin cancer cases including melanoma and non-melanoma are the major factors contributes, to drive the growth of skin cancer treatment market size. For instance, according to the Skin Cancer Foundation, U.S. has reported about 3.6 million populations with basal cell carcinoma and 1.8 million people with squamous cell carcinoma in 2022. From the same report it was estimated that, skin cancer is most common type of cancer in the U.S. 1 in 5 Americans will develop skin cancer and more than 2 people die with skin cancer.

In addition, increase in initiative taken by government and key players involved in manufacturing and development of innovative therapeutics in the healthcare sector for effective treatment of skin cancer are some skin cancer treatment market trends leads to the market growth.  For instance, in 2020, Genentech, a member of leading pharmaceutical company Roche announced the product approval from Food and Drug Administration (FDA) for products Tecentriq (atezolizumab) and Cotellic (cobimetinib) collectively to treat patients with BRAF V600 mutation effectively.  

Furthermore, rise in product approvals for effective management of skin cancer by regulatory authorities also boost the market growth. For instance, in 2021, the FDA announced approval of the first immunotherapy product, PD-1 inhibitor Libtayo to treat basal cell carcinoma, which has a higher chance of success than the previously used hedgehog pathway inhibitor (HHI). Increased demand for immunotherapy and targeted based therapy treatments and increased awareness about skin cancer treatments are the opportunities for market growth in forecast period. However, side effects associated with use of chemotherapy for skin cancer treatment hampers the market growth.

COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. The global skin cancer treatment industry also declined in 2020 due to global economic recession led by COVID-19. The main factor is the delays in care, that patients with skin cancer experience in hospitals because of the possibility of contracting COVID-19 infection. The COVID-19 global public health crisis has had an effect on almost every industry.

The global skin cancer treatment market is segmented by type, therapy, distribution channel and region. By type, the market is classified into melanoma and non-melanoma. By therapy, the market is classified into immunotherapy, targeted therapy, and chemotherapy. By distribution channel, the market is classified into hospitals pharmacies, drug stores & retail pharmacies and online providers. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Depending on type, the market is divided into melanoma and non- melanoma. The melanoma segment dominated the market in 2021, and is also expected to witness highest CAGR during skin cancer treatment market forecast, owing to increase in number of populations affected with melanoma. The non-melanoma type segment is expected to grow during the forecast period, owing to increase in number of populations with non-melanoma and product launches for non-melanoma type of skin cancer treatment.

Depending on therapy, the market is divided into immunotherapy, targeted therapy, and chemotherapy. The immunotherapy segment dominated the market in 2021, and is also expected to witness highest CAGR during the forecast period, owing to increase in demand for immunotherapy-based skin cancer treatments and minimum side effects associated with use of immunotherapy drugs. The targeted therapy segment is estimated to grow during the forecast period, owing to increase in product launches, less side effects associated with targeted based therapies, higher efficacy, and accuracy.

Depending on distribution channel, the market is divided into hospital pharmacies, drug store & retail pharmacies and online providers. The drug stores & retail pharmacies segment dominated the market in 2021, owing to its presence in commercial areas of the community. The online provider segment is expected to witness highest CAGR of during the forecast period, owing to popular medium for purchase of medicines.

By region, North America accounted for majority of the global skin cancer treatment market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to technological advancements in skin cancer treatment techniques, R & D of advanced drugs for allergic conjunctivitis and presence of key and robust hospital infrastructure in the region. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in patient population, development of healthcare infrastructure, and increase in investment projects in the region.

KEY FINDINGS OF THE STUDY 
• By type, the melanoma segment was the highest contributor to the skin cancer treatment industry in 2021.
• By therapy, the immunotherapy segment was the highest contributor to the market in 2021.
• Depending on distribution channel, the drug stores & retail pharmacies segment was the highest contributor in 2021, and is expected to continue this trend during the forecast period.
• Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the skin cancer treatment market analysis.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Tushar Nagose
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote Skin Cancer Treatment Market by Type (Melanoma, Non-Melanoma), by Therapy (Immunotherapy, Targeted Therapy, Chemotherapy), by Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2031 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date Feb 2023

Hvac Actuators Market

Download Sample
rep-img

Published Date Feb 2023

Video Door Phones Market

Download Sample
 

Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

 
Get Industry Data Alerts
 

Buy Full Version
"Skin Cancer Treatment Market"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers